Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1441.420
- -3.955-0.27%
Here's the Major Earnings Before the Open Tomorrow
Wall Street Today: Market Quaking With Anticipation, and Nvidia Delivers Beat
Agilent Technologies Non-GAAP EPS of $1.31 Beats by $0.04, Revenue of $1.68B Beats by $10M
10 Health Care Stocks Whale Activity In Today's Session
Beam Therapeutics Analyst Ratings
Live Stock News: Market Climbs Back From Tech Pit, Awaits Prodigal Semi Son to Report
Here Are the Major Earnings After the Close Today
Eyenovia Regains Compliance With Nasdaq
Earnings Scheduled For February 26, 2025
AIX Receives Minimum Bid Price Notice From Nasdaq
Wall Street Today: All Fun and Games Until Consumers Get Uneasy
Express News | Ukraine Agrees to U.S. Mineral Deal: Financial Times
Peering Into Editas Medicine's Recent Short Interest
Is Vertex Pharmaceuticals Gaining or Losing Market Support?
Live Stock News: Tesla, Bitcoin, Major Mag Seven Tech Pullback
Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor
Wall Street Today: Market Had Us in the First Half, Not Gonna Lie
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
Bluebird Bio Stock Slides for Second Day on Buyout News
Live Stock News: Apple Pulling $500B For U.S. AI, But is it Enough to Move the Needle